{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T18:11:20Z","timestamp":1781115080925,"version":"3.54.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T00:00:00Z","timestamp":1583193600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T00:00:00Z","timestamp":1583193600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81371599"],"award-info":[{"award-number":["81371599"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873904"],"award-info":[{"award-number":["81873904"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s11307-019-01467-7","type":"journal-article","created":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T14:02:48Z","timestamp":1583244168000},"page":"1043-1053","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Radiotheranostic Targeting Cancer Stem Cells in Human Colorectal Cancer Xenografts"],"prefix":"10.1007","volume":"22","author":[{"given":"Xianliang","family":"She","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saimei","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boping","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7263-7399","authenticated-orcid":false,"given":"Xiaoli","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,3]]},"reference":[{"key":"1467_CR1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87\u2013108","journal-title":"CA Cancer J Clin"},{"key":"1467_CR2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Jemal A (2017) Cancer statistics, 2017. CA Cancer J Clin 67:7\u201330","journal-title":"CA Cancer J Clin"},{"key":"1467_CR3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3322\/caac.21395","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RGS, Barzi A, Jemal A (2017) Colorectal cancer statistics, 2017. CA Cancer J Clin 67:177\u2013193","journal-title":"CA Cancer J Clin"},{"key":"1467_CR4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature05384","volume":"445","author":"L Ricci-Vitiani","year":"2007","unstructured":"Ricci-Vitiani L, Lombardi DG, Pilozzi E et al (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445:111\u2013115","journal-title":"Nature"},{"key":"1467_CR5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature05372","volume":"445","author":"CA O'Brien","year":"2007","unstructured":"O'Brien CA, Pollett A, Gallinger S, Dick JE (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445:106\u2013110","journal-title":"Nature"},{"key":"1467_CR6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.gde.2003.11.007","volume":"14","author":"M Al-Hajj","year":"2004","unstructured":"Al-Hajj M, Becker MW, Wicha M et al (2004) Therapeutic implications of cancer stem cells. Curr Opin Genet Dev 14:43\u201347","journal-title":"Curr Opin Genet Dev"},{"key":"1467_CR7","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nrc1650","volume":"5","author":"JJ Kim","year":"2005","unstructured":"Kim JJ, Tannock IF (2005) Repopulation of cancer cells during therapy: an important cause of treatment failure. Nat Rev Cancer 5:516\u2013525","journal-title":"Nat Rev Cancer"},{"key":"1467_CR8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.semcancer.2014.06.004","volume":"31","author":"M Cojoc","year":"2015","unstructured":"Cojoc M, M\u00e4bert K, Muders MH, Dubrovska A (2015) A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms. Semin Cancer Biol 31:16\u201327","journal-title":"Semin Cancer Biol"},{"key":"1467_CR9","doi-asserted-by":"crossref","first-page":"9339","DOI":"10.1158\/0008-5472.CAN-06-3126","volume":"66","author":"MF Clarke","year":"2006","unstructured":"Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL, Wahl GM (2006) Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66:9339\u20139344","journal-title":"Cancer Res"},{"key":"1467_CR10","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1582-4934.2007.00211.x","volume":"12","author":"AK Croker","year":"2008","unstructured":"Croker AK, Allan AL (2008) Cancer stem cells: implications for the progression and treatment of metastatic disease. J Cell Mol Med 12:374\u2013390","journal-title":"J Cell Mol Med"},{"key":"1467_CR11","doi-asserted-by":"crossref","first-page":"10158","DOI":"10.1073\/pnas.0703478104","volume":"104","author":"P Dalerba","year":"2007","unstructured":"Dalerba P, Dylla SJ, Park IK et al (2007) Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A 104:10158\u201310163","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1467_CR12","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1245\/s10434-008-0074-0","volume":"15","author":"N Haraguchi","year":"2008","unstructured":"Haraguchi N, Ohkuma M, Sakashita H, Matsuzaki S, Tanaka F, Mimori K, Kamohara Y, Inoue H, Mori M (2008) CD133+CD44+ population efficiently enriches colon cancer initiating cells. Ann Surg Oncol 15:2927\u20132933","journal-title":"Ann Surg Oncol"},{"key":"1467_CR13","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1158\/0008-5472.CAN-15-2455","volume":"76","author":"LE Gerweck","year":"2016","unstructured":"Gerweck LE, Wakimoto H (2016) At the crossroads of cancer stem cells, radiation biology, and radiation oncology. Cancer Res 76:994\u2013998","journal-title":"Cancer Res"},{"key":"1467_CR14","doi-asserted-by":"crossref","first-page":"e94621","DOI":"10.1371\/journal.pone.0094621","volume":"9","author":"SH Sahlberg","year":"2014","unstructured":"Sahlberg SH, Spiegelberg D, Glimelius B et al (2014) Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells. PLoS One 9:e94621","journal-title":"PLoS One"},{"key":"1467_CR15","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1158\/0008-5472.CAN-16-2523","volume":"77","author":"DJ Green","year":"2017","unstructured":"Green DJ, Press OW (2017) Whither radioimmunotherapy: to be or not to be? Cancer Res 77:2191\u20132196","journal-title":"Cancer Res"},{"key":"1467_CR16","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1148\/radiol.2017170346","volume":"286","author":"H Jadvar","year":"2018","unstructured":"Jadvar H, Chen X, Cai W, Mahmood U (2018) Radiotheranostics in cancer diagnosis and management. Radiology 286:388\u2013400","journal-title":"Radiology"},{"key":"1467_CR17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF01789048","volume":"32","author":"RD Blumenthal","year":"1991","unstructured":"Blumenthal RD, Kashi R, Stephens R, Sharkey RM, Goldenberg DM (1991) Improved radioimmunotherapy of colorectal cancer xenografts using antibody mixtures against carcinoembryonic antigen and colon-specific antigen-p. Cancer Immunol Immunother 32:303\u2013310","journal-title":"Cancer Immunol Immunother"},{"key":"1467_CR18","first-page":"1811","volume":"2","author":"RF Meredith","year":"1996","unstructured":"Meredith RF, Khazaeli MB, Plott WE et al (1996) Phase II study of dual 131I-labeled monoclonal antibody therapy with interferon in patients with metastatic colorectal cancer. Clin Cancer Res 2:1811\u20131818","journal-title":"Clin Cancer Res"},{"key":"1467_CR19","doi-asserted-by":"crossref","first-page":"7075s","DOI":"10.1158\/1078-0432.CCR-1004-0008","volume":"11","author":"GL DeNardo","year":"2005","unstructured":"DeNardo GL, Tobin E, Chan K et al (2005) Direct antilymphoma effects on human lymphoma cells of monotherapy and combination therapy with CD20 and HLA-DR antibodies and 90Y-labeled HLA-DR antibodies. Clin Cancer Res 11:7075s\u20137079s","journal-title":"Clin Cancer Res"},{"key":"1467_CR20","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/cncr.24793","volume":"116","author":"DE Milenic","year":"2010","unstructured":"Milenic DE, Brady ED, Garmestani K, Albert PS, Abdulla A, Brechbiel MW (2010) Improved efficacy of alpha-particle-targeted radiation therapy: dual targeting of human epidermal growth factor receptor-2 and tumor-associated glycoprotein 72. Cancer 116:1059\u20131066","journal-title":"Cancer"},{"key":"1467_CR21","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2217\/imt.10.114","volume":"3","author":"RM Sharkey","year":"2011","unstructured":"Sharkey RM, Goldenberg DM (2011) Cancer radioimmunotherapy. Immunotherapy 3:349\u2013370","journal-title":"Immunotherapy"},{"key":"1467_CR22","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.2967\/jnumed.114.141580","volume":"55","author":"JB Pasternack","year":"2014","unstructured":"Pasternack JB, Domogauer JD, Khullar A et al (2014) The advantage of antibody cocktails for targeted alpha therapy depends on specific activity. J Nucl Med 55:2012\u20132019","journal-title":"J Nucl Med"},{"key":"1467_CR23","doi-asserted-by":"crossref","first-page":"5921","DOI":"10.1158\/0008-5472.CAN-07-0080","volume":"67","author":"JM Pagel","year":"2007","unstructured":"Pagel JM, Pantelias A, Hedin N, Wilbur S, Saganic L, Lin Y, Axworthy D, Hamlin DK, Wilbur DS, Gopal AK, Press OW (2007) Evaluation of CD20, CD22, and HLA-DR targeting for radioimmunotherapy of B-cell lymphomas. Cancer Res 67:5921\u20135928","journal-title":"Cancer Res"},{"key":"1467_CR24","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.nucmedbio.2015.01.003","volume":"42","author":"J Lang","year":"2015","unstructured":"Lang J, Lan X, Liu Y et al (2015) Targeting cancer stem cells with an 131I-labeled anti-AC133 monoclonal antibody in human colorectal cancer xenografts. Nucl Med Biol 42:505\u2013512","journal-title":"Nucl Med Biol"},{"key":"1467_CR25","doi-asserted-by":"crossref","first-page":"44004","DOI":"10.18632\/oncotarget.16868","volume":"8","author":"D Weng","year":"2017","unstructured":"Weng D, Jin X, Qin S, Lan X, Chen C, Sun X, She X, Dong C, An R (2017) Radioimmunotherapy for CD133(+) colonic cancer stem cells inhibits tumor development in nude mice. Oncotarget 8:44004\u201344014","journal-title":"Oncotarget"},{"key":"1467_CR26","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/sj.bjc.6605642","volume":"102","author":"P Workman","year":"2010","unstructured":"Workman P, Aboagye EO, Balkwill F, Balmain A, Bruder G, Chaplin DJ, Double JA, Everitt J, Farningham DA, Glennie MJ, Kelland LR, Robinson V, Stratford IJ, Tozer GM, Watson S, Wedge SR, Eccles SA, Committee of the National Cancer Research Institute (2010) Guidelines for the welfare and use of animals in cancer research. Br J Cancer 102:1555\u20131577","journal-title":"Br J Cancer"},{"key":"1467_CR27","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrc3925","volume":"15","author":"SM Larson","year":"2015","unstructured":"Larson SM, Carrasquillo JA, Cheung NK, Press OW (2015) Radioimmunotherapy of human tumours. Nat Rev Cancer 15:347\u2013360","journal-title":"Nat Rev Cancer"},{"issue":"Suppl 1","key":"1467_CR28","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","volume":"50","author":"RL Wahl","year":"2009","unstructured":"Wahl RL, Jacene H, Kasamon Y, Lodge MA (2009) From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med 50(Suppl 1):122S\u2013150S","journal-title":"J Nucl Med"},{"key":"1467_CR29","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1007\/s00259-015-3260-x","volume":"43","author":"D Spiegelberg","year":"2016","unstructured":"Spiegelberg D, Mortensen AC, Selvaraju RK, Eriksson O, Stenerl\u00f6w B, Nestor M (2016) Molecular imaging of EGFR and CD44v6 for prediction and response monitoring of HSP90 inhibition in an in vivo squamous cell carcinoma model. Eur J Nucl Med Mol Imaging 43:974\u2013982","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1467_CR30","first-page":"731","volume":"9","author":"S Lin","year":"2016","unstructured":"Lin S, Xu Y, Gan Z, Han K, Hu H, Yao Y, Huang M, Min D (2016) Monitoring cancer stem cells: insights into clinical oncology. Onco Targets Ther 9:731\u2013740","journal-title":"Onco Targets Ther"},{"key":"1467_CR31","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1158\/0008-5472.CAN-08-2023","volume":"69","author":"NA Dallas","year":"2009","unstructured":"Dallas NA, Xia L, Fan F, Gray MJ, Gaur P, van Buren G 2nd, Samuel S, Kim MP, Lim SJ, Ellis LM (2009) Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition. Cancer Res 69:1951\u20131957","journal-title":"Cancer Res"},{"key":"1467_CR32","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.3892\/or.2012.1951","volume":"28","author":"C Wang","year":"2012","unstructured":"Wang C, Xie J, Guo J, Manning HC, Gore JC, Guo N (2012) Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer. Oncol Rep 28:1301\u20131308","journal-title":"Oncol Rep"},{"key":"1467_CR33","doi-asserted-by":"crossref","first-page":"44191","DOI":"10.18632\/oncotarget.6176","volume":"6","author":"T Wang","year":"2015","unstructured":"Wang T, Shigdar S, Gantier MP, Hou Y, Wang L, Li Y, Shamaileh HA, Yin W, Zhou SF, Zhao X, Duan W (2015) Cancer stem cell targeted therapy: progress amid controversies. Oncotarget 6:44191\u201344206","journal-title":"Oncotarget"},{"key":"1467_CR34","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1227\/NEU.0b013e3181ff9eb5","volume":"68","author":"M Rahman","year":"2011","unstructured":"Rahman M, Deleyrolle L, Vedam-Mai V et al (2011) The cancer stem cell hypothesis: failures and pitfalls. Neurosurgery 68:531\u2013545","journal-title":"Neurosurgery"},{"key":"1467_CR35","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jso.23069","volume":"106","author":"BA Grotenhuis","year":"2012","unstructured":"Grotenhuis BA, Wijnhoven BP, van Lanschot JJ (2012) Cancer stem cells and their potential implications for the treatment of solid tumors. J Surg Oncol 106:209\u2013215","journal-title":"J Surg Oncol"},{"key":"1467_CR36","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1158\/0008-5472.CAN-14-0266","volume":"74","author":"T Yang","year":"2014","unstructured":"Yang T, Rycaj K, Liu ZM, Tang DG (2014) Cancer stem cells: constantly evolving and functionally heterogeneous therapeutic targets. Cancer Res 74:2922\u20132927","journal-title":"Cancer Res"},{"key":"1467_CR37","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.molmed.2008.08.003","volume":"14","author":"T Klonisch","year":"2008","unstructured":"Klonisch T, Wiechec E, Hombach-Klonisch S et al (2008) Cancer stem cell markers in common cancers - therapeutic implications. Trends Mol Med 14:450\u2013460","journal-title":"Trends Mol Med"},{"key":"1467_CR38","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1158\/0008-5472.CAN-09-3663","volume":"70","author":"A Sottoriva","year":"2010","unstructured":"Sottoriva A, Verhoeff JJ, Borovski T et al (2010) Cancer stem cell tumor model reveals invasive morphology and increased phenotypical heterogeneity. Cancer Res 70:46\u201356","journal-title":"Cancer Res"},{"key":"1467_CR39","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature22081","volume":"545","author":"M Shimokawa","year":"2017","unstructured":"Shimokawa M, Ohta Y, Nishikori S et al (2017) Visualization and targeting of LGR5(+) human colon cancer stem cells. Nature 545:187\u2013192","journal-title":"Nature"},{"key":"1467_CR40","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.2967\/jnumed.117.199570","volume":"58","author":"K Herrmann","year":"2017","unstructured":"Herrmann K, Larson SM, Weber WA (2017) Theranostic concepts: more than just a fashion trend-introduction and overview. J Nucl Med 58:1S\u20132S","journal-title":"J Nucl Med"},{"key":"1467_CR41","doi-asserted-by":"crossref","first-page":"812","DOI":"10.2967\/jnumed.113.133850","volume":"55","author":"C Qin","year":"2014","unstructured":"Qin C, Liu H, Chen K et al (2014) Theranostics of malignant melanoma with 64CuCl2. J Nucl Med 55:812\u2013817","journal-title":"J Nucl Med"},{"key":"1467_CR42","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.2967\/jnumed.114.141614","volume":"55","author":"C Muller","year":"2014","unstructured":"Muller C, Bunka M, Haller S et al (2014) Promising prospects for 44Sc-\/47Sc-based theragnostics: application of 47Sc for radionuclide tumor therapy in mice. J Nucl Med 55:1658\u20131664","journal-title":"J Nucl Med"},{"key":"1467_CR43","doi-asserted-by":"crossref","first-page":"83S","DOI":"10.2967\/jnumed.116.186940","volume":"58","author":"KL Moek","year":"2017","unstructured":"Moek KL, Giesen D, Kok IC, de Groot DJA, Jalving M, Fehrmann RSN, Lub-de Hooge MN, Brouwers AH, de Vries EGE (2017) Theranostics using antibodies and antibody-related therapeutics. J Nucl Med 58:83S\u201390S","journal-title":"J Nucl Med"},{"key":"1467_CR44","doi-asserted-by":"crossref","first-page":"E692","DOI":"10.1073\/pnas.1314189111","volume":"111","author":"S Gaedicke","year":"2014","unstructured":"Gaedicke S, Braun F, Prasad S, Machein M, Firat E, Hettich M, Gudihal R, Zhu X, Klingner K, Sch\u00fcler J, Herold-Mende CC, Grosu AL, Behe M, Weber W, M\u00e4cke H, Niedermann G (2014) Noninvasive positron emission tomography and fluorescence imaging of CD133+ tumor stem cells. Proc Natl Acad Sci U S A 111:E692\u2013E701","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1467_CR45","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.nucmedbio.2010.08.009","volume":"38","author":"Y Yoshii","year":"2011","unstructured":"Yoshii Y, Furukawa T, Kiyono Y, Watanabe R, Mori T, Yoshii H, Asai T, Okazawa H, Welch MJ, Fujibayashi Y (2011) Internal radiotherapy with copper-64-diacetyl-bis (N4-methylthiosemicarbazone) reduces CD133+ highly tumorigenic cells and metastatic ability of mouse colon carcinoma. Nucl Med Biol 38:151\u2013157","journal-title":"Nucl Med Biol"},{"key":"1467_CR46","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.addr.2015.12.003","volume":"109","author":"S Aghevlian","year":"2017","unstructured":"Aghevlian S, Boyle AJ, Reilly RM (2017) Radioimmunotherapy of cancer with high linear energy transfer (LET) radiation delivered by radionuclides emitting alpha-particles or Auger electrons. Adv Drug Deliv Rev 109:102\u2013118","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-019-01467-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11307-019-01467-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-019-01467-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T00:52:06Z","timestamp":1614732726000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11307-019-01467-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,3]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["1467"],"URL":"https:\/\/doi.org\/10.1007\/s11307-019-01467-7","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,3]]},"assertion":[{"value":"3 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All applicable institutional and\/or national guidelines for the care and use of animals were followed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}